Chemours (NYSE:CC)

CAPS Rating: 2 out of 5

Results 1 - 2 of 2

Recs

0
Member Avatar OklaBoston (64.23) Submitted: 1/11/2016 10:52:13 PM : Outperform Start Price: $4.44 CC Score: -3.05

Far enough below it's IPO price to be worth taking a risk on despite scarily high debt.

Recs

0
Member Avatar Junkyardhawg1985 (54.11) Submitted: 7/30/2015 9:53:22 AM : Outperform Start Price: $11.51 CC Score: -53.50

Chemours (CC) at $11.36/sh has two likely outcomes. First they may get overcome by the debt and liablities added by DuPont (low probability). The second more likely outcome is that the company will get back to a normal EV/Rev ratio of 2. If this happens, the stock should quadrouple.

Results 1 - 2 of 2

Featured Broker Partners